The usefulness of 18F-FDG PET/CT for assessing methotrexate-associated lymphoproliferative disorder (MTX-LPD)

The usefulness of 18F-FDG PET/CT for assessing methotrexate-associated lymphoproliferative disorder (MTX-LPD)

Bibliographic Details
Main Authors:	Watanabe, Shiro, Manabe, Osamu, Hirata, Kenji, Oyama-Manabe, Noriko, Hattori, Naoya, Kikuchi, Yasuka, Kobayashi, Kentaro, Toyonaga, Takuya, Tamaki, Nagara
Format:	Online
Language:	English
Published:	BioMed Central 2016
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4986273/

Similar Items

A Semi-Automated Technique Determining the Liver Standardized Uptake Value Reference for Tumor Delineation in FDG PET-CT
by: Hirata, Kenji, et al.
Published: (2014)

Somatic changes in B-lymphoproliferative disorders (B-LPD) detected by DNA-fingerprinting.
by: de Jong, D., et al.
Published: (1988)

Treatment of methotrexate (MTX) intolerance: behavioural therapy, versus switch to parenteral MTX versus oral MTX
by: Verkaaik, M, et al.
Published: (2011)

The effects of 18-h fasting with low-carbohydrate diet preparation on suppressed physiological myocardial 18F-fluorodeoxyglucose (FDG) uptake and possible minimal effects of unfractionated heparin use in patients with suspected cardiac involvement sarcoidosis
by: Manabe, Osamu, et al.
Published: (2015)

Monoclonal antibody targeting of methotrexate (MTX) against MTX-resistant tumour cell lines.
by: Affleck, K., et al.
Published: (1992)

PET/CT scanning with 3D acquisition is feasible for quantifying myocardial blood flow when diagnosing coronary artery disease
by: Osamu Manabe, et al.
Published: (2017-06-01)

Overexpression of Activation-Induced Cytidine Deaminase in MTX- and Age-Related Epstein-Barr Virus-Associated B-Cell Lymphoproliferative Disorders of the Head and Neck
by: Kikuchi, Kentaro, et al.
Published: (2015)

The GO-DACT protocol: a multicentre, randomized, double-blind, parallel-group study to compare the efficacy of golimumab in combination with methotrexate (MTX) versus MTX monotherapy
by: Elsa Vieira-Sousa, et al.
Published: (2018-04-01)

Lung uptake on I-131 therapy and short-term outcome in patients with lung metastasis from differentiated thyroid cancer
by: Okamoto, Shozo, et al.
Published: (2013)

Safety and efficacy of ocrelizumab in combination with methotrexate in MTX-naive subjects with rheumatoid arthritis: the phase III FILM trial
by: Stohl, William, et al.
Published: (2012)

Identification and Characterization of the Direct Interaction between Methotrexate (MTX) and High-Mobility Group Box 1 (HMGB1) Protein
by: Kuroiwa, Yuki, et al.
Published: (2013)

Methotrexate-induced CD30+ T-cell lymphoproliferative disorder of the oral cavity
by: Saleh, Jamal Z., et al.
Published: (2016)

LETTER TO THE EDITOR Subcutaneous (SC) Methotrexate (MTX) is Better and Well-Tolerable than Oral MTX in Rheumatoid Arthritis Patients, Switched from Oral to SC Administration Due to Gastrointestinal Side Effects
by: Borman, Pinar, et al.
Published: (2014)

Methotrexate-related lymphoproliferative disorder of the stomach in a patient with rheumatoid arthritis: a case of disease regression after methotrexate cessation
by: Ikeda, Kazuki, et al.
Published: (2016)

Non-Coronary Cardiac Findings and Pitfalls in Coronary Computed Tomography Angiography
by: Oyama-Manabe, Noriko, et al.
Published: (2011)

Investigating which variables from the core outcome variables in juvenile idiopathic arthritis (JIA) are the best predictors of classification as a responder to treatment with methotrexate (MTX)
by: Hirani, SP, et al.
Published: (2008)

Complete Remission of Methotrexate-Related Epstein-Barr-Virus-Associated Hodgkin-Like Lymphoma following Withdrawal of MTX Coupled with Clarithromycin Administration
by: Takemori, Nobuo, et al.
Published: (2012)

Systemic Oxidative Stress Is Associated With Lower Aerobic Capacity and Impaired Skeletal Muscle Energy Metabolism in Patients With Metabolic Syndrome
by: Yokota, Takashi, et al.
Published: (2013)

Change in 18F-Fluoromisonidazole PET Is an Early Predictor of the Prognosis in the Patients with Recurrent High-Grade Glioma Receiving Bevacizumab Treatment
by: Yamaguchi, Shigeru, et al.
Published: (2016)

FDG-PET Findings of Intraductal Oncocytic Papillary Neoplasms of the Pancreas: Two Case Reports
by: Kato, Takashi, et al.
Published: (2012)

Reproducibility and uptake time dependency of volume-based parameters on FDG-PET for lung cancer
by: Kitao, Tomoka, et al.
Published: (2016)

Relationship between clinical and patient-reported outcomes in a phase 3 trial of tofacitinib or MTX in MTX-naïve patients with rheumatoid arthritis
by: Fleischmann, Roy, et al.
Published: (2016)

Improvement of cerebral hypometabolism after resection of radiation-induced necrotic lesion in a patient with cerebral arteriovenous malformation
by: Harada, Yae, et al.
Published: (2015)

Primary Hepatic Lymphoma in a Patient with Rheumatoid Arthritis Treated with Methotrexate
by: Tatsumi, Goichi, et al.
Published: (2014)

Treatment of Recurrent Posttransplant Lymphoproliferative Disorder of the Central Nervous System with High-Dose Methotrexate
by: Twist, Clare J., et al.
Published: (2013)

Atypical methotrexate ulcerative stomatitis with features of lymphoproliferative like disorder: Report of a rare ciprofloxacin-induced case and review of the literature
by: Katsoulas, Nikolaos, et al.
Published: (2016)

High-flux hemodialysis after administering high-dose methotrexate in a patient with posttransplant lymphoproliferative disease and impaired renal function
by: Reshetnik, Alexander, et al.
Published: (2015)

Proposal for a Conceptual Model for Evaluating Lean Product Development Performance: A Study of LPD Enablers in Manufacturing Companies
by: Aikhuele, Daniel Osezua, et al.
Published: (2016)

Lpd depletion reveals that SRF specifies radial versus tangential migration of pyramidal neurons
by: Pinheiro, Elaine M., et al.
Published: (2011)

Impact of topically‐applied lpd‐glucose on tracheal mucociliary clearance after warm and cold ischemia: short communication
by: de Azevedo‐Pereira, Artur Eugênio, et al.
Published: (2011)

A Risk Prediction Model for Redislocation Following First Time Lateral Patellar Dislocation (LPD)
by: Tompkins, Marc, et al.
Published: (2016)

Monocyte populations as markers of response to adalimumab plus MTX in rheumatoid arthritis
by: Chara, Luis, et al.
Published: (2012)

Serious infections in JIA patients upon MTX, TFN inhibitors and combinations
by: Horneff, Gerd, et al.
Published: (2014)

Posttransplant Lymphoproliferative Disorder of the Thorax: CT and FDG-PET Features in a Single Tertiary Referral Center
by: Yoon, Ga Young, et al.
Published: (2015)

Posttransplant Lymphoproliferative Disorders
by: Ibrahim, Hazem A. H., et al.
Published: (2012)

Malignant Lymphoproliferative Diseases
by: Garrett, J. V.
Published: (1981)

JAK-STAT in lymphoproliferative disorders
by: Rabadan, Raul, et al.
Published: (2015)

Imaging of Myocardial Oxidative Metabolism in Heart Failure
by: Naya, Masanao, et al.
Published: (2013)

Accelerated 99mTc-sestamibi clearance associated with mitochondrial dysfunction and regional left ventricular dysfunction in reperfused myocardium in patients with acute coronary syndrome
by: Masuda, Atsuro, et al.
Published: (2016)

Microdosimetric Analysis Confirms Similar Biological Effectiveness of External Exposure to Gamma-Rays and Internal Exposure to 137Cs, 134Cs, and 131I
by: Sato, Tatsuhiko, et al.
Published: (2014)